Cargando…
Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions
Surgical management with enucleation was the primary treatment for uveal melanoma (UM) for over 100 years. The Collaborative Ocular Melanoma Study confirmed in 2001 that globe-preserving episcleral brachytherapy for UM was safe and effective, demonstrating no survival difference with enucleation. To...
Autores principales: | Brewington, Beatrice Y, Shao, Yusra F, Davidorf, Fredrick H, Cebulla, Colleen M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963830/ https://www.ncbi.nlm.nih.gov/pubmed/29844657 http://dx.doi.org/10.2147/OPTH.S129645 |
Ejemplares similares
-
Long-Term Survivors with Metastatic Uveal Melanoma
por: Buzzacco, Dominic M, et al.
Publicado: (2012) -
Heterogeneity in Mitogen-Activated Protein Kinase (MAPK) Pathway Activation in Uveal Melanoma With Somatic GNAQ and GNA11 Mutations
por: Boru, Getachew, et al.
Publicado: (2019) -
Genetic markers of pigmentation are novel risk loci for uveal melanoma
por: Ferguson, Robert, et al.
Publicado: (2016) -
Brachytherapy of Uveal Melanomas with Ruthenium-106 Plaques
por: Belaïd, Asma, et al.
Publicado: (2016) -
Ruthenium brachytherapy for uveal melanoma – single institution experience
por: Rospond-Kubiak, Iwona, et al.
Publicado: (2017)